The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1
- PMID: 16672235
- PMCID: PMC2242534
- DOI: 10.1110/ps.062128706
The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1
Abstract
The receptor-type protein tyrosine phosphatases (RPTPs) are integral membrane proteins composed of extracellular adhesion molecule-like domains, a single transmembrane domain, and a cytoplasmic domain. The cytoplasmic domain consists of tandem PTP domains, of which the D1 domain is enzymatically active. RPTPkappa is a member of the R2A/IIb subfamily of RPTPs along with RPTPmu, RPTPrho, and RPTPlambda. Here, we have determined the crystal structure of catalytically active, monomeric D1 domain of RPTPkappa at 1.9 A. Structural comparison with other PTP family members indicates an overall classical PTP architecture of twisted mixed beta-sheets flanked by alpha-helices, in which the catalytically important WPD loop is in an unhindered open conformation. Though the residues forming the dimeric interface in the RPTPmu structure are all conserved, they are not involved in the protein-protein interaction in RPTPkappa. The N-terminal beta-strand, formed by betax association with betay, is conserved only in RPTPs but not in cytosolic PTPs, and this feature is conserved in the RPTPkappa structure forming a beta-strand. Analytical ultracentrifugation studies show that the presence of reducing agents and higher ionic strength are necessary to maintain RPTPkappa as a monomer. In this family the crystal structure of catalytically active RPTPmu D1 was solved as a dimer, but the dimerization was proposed to be a consequence of crystallization since the protein was monomeric in solution. In agreement, we show that RPTPkappa is monomeric in solution and crystal structure.
Figures


Similar articles
-
The crystal structure of domain 1 of receptor protein-tyrosine phosphatase mu.J Biol Chem. 1997 Oct 31;272(44):27505-8. doi: 10.1074/jbc.272.44.27505. J Biol Chem. 1997. PMID: 9346878
-
Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.J Mol Biol. 2001 Aug 17;311(3):557-68. doi: 10.1006/jmbi.2001.4890. J Mol Biol. 2001. PMID: 11493009
-
Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.J Mol Biol. 2005 Nov 18;354(1):150-63. doi: 10.1016/j.jmb.2005.09.049. Epub 2005 Oct 3. J Mol Biol. 2005. PMID: 16226275
-
Mechanistic studies on protein tyrosine phosphatases.Prog Nucleic Acid Res Mol Biol. 2003;73:171-220. doi: 10.1016/s0079-6603(03)01006-7. Prog Nucleic Acid Res Mol Biol. 2003. PMID: 12882518 Review.
-
Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases.Biochem Cell Biol. 2004 Dec;82(6):664-75. doi: 10.1139/o04-120. Biochem Cell Biol. 2004. PMID: 15674434 Review.
Cited by
-
Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and Fyn.EMBO J. 2009 Nov 18;28(22):3564-78. doi: 10.1038/emboj.2009.289. Epub 2009 Oct 8. EMBO J. 2009. PMID: 19816407 Free PMC article.
-
The receptor PTPRU is a redox sensitive pseudophosphatase.Nat Commun. 2020 Jun 26;11(1):3219. doi: 10.1038/s41467-020-17076-w. Nat Commun. 2020. PMID: 32591542 Free PMC article.
-
Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases.Bioorg Med Chem. 2015 Jun 15;23(12):2828-38. doi: 10.1016/j.bmc.2015.03.027. Epub 2015 Mar 17. Bioorg Med Chem. 2015. PMID: 25828055 Free PMC article.
-
Chemical activation of divergent protein tyrosine phosphatase domains with cyanine-based biarsenicals.Sci Rep. 2019 Nov 6;9(1):16148. doi: 10.1038/s41598-019-52002-1. Sci Rep. 2019. PMID: 31695052 Free PMC article.
-
The lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cells.Mol Cell Biol. 2011 Aug;31(16):3286-97. doi: 10.1128/MCB.01426-10. Epub 2011 Jun 20. Mol Cell Biol. 2011. PMID: 21690299 Free PMC article.
References
-
- Alonso A., Sasin J., Bottini N., Friedberg I., Friedberg I., Osterman A., Godzik A., Hunter T., Dixon J., Mustelin T. 2004. Protein tyrosine phosphatases in the human genome Cell 117 699–711. - PubMed
-
- Barford D., Flint A.J., Tonks N.K. 1994. Crystal structure of human protein tyrosine phosphatase 1B Science 263 1397–1404. - PubMed
-
- Bilwes A.M., den Hertog J., Hunter T., Noel J.P. 1996. Structural basis for inhibition of receptor protein–tyrosine phosphatase-α by dimerization Nature 382 555–559. - PubMed
-
- Desai D.M., Sap J., Schlessinger J., Weiss A. 1993. Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase Cell 73 541–554. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources